There are some pharma stocks to sell in April. Holding these companies is too risky, especially as the industry faces increasing regulatory scrutiny and pricing pressures. Several major pharmaceutical firms are grappling with patent cliffs, where key drug exclusivities are expiring. This opens the door for generic competition. Moreover, with the broader market presenting attractive
0 Comments
Investors buy growth stocks, hoping that those investments will outperform the stock market. Growth stocks to buy tend to perform especially well during bullish markets, as investors experienced in 2023 and the start of 2024.  The Nasdaq Composite and the S&P 500 are both up by roughly 10% year-to-date. Many growth stocks have generated higher returns than those indices.
0 Comments
Implementing an investment strategy of buying low-priced stocks may not be for everyone. But if you’re a growth-oriented investor who’s willing to accept a level of risk, stocks under $7 can be both appealing and profitable. These stocks under $7 have greater potential for substantial gains because they start off with lower valuations. It’s much
0 Comments
Some traders are buying Super Micro Computer (NASDAQ:SMCI) stock because the company sells artificial intelligence enabled servers. They’re looking for the “next” Nvidia (NASDAQ:NVDA). It’s a dangerous quest, though, and this is the worst possible time to invest Super Micro Computer stock. Truly, this is a recipe for disaster. As we’ll discover, the sentiment and
0 Comments